Evaluation and Follow-up of Individuals With Obsessive-Compulsive Disorder and Related Conditions

The Evaluation and Follow-up of Patients With Obsessive-Compulsive Disorder and OC Spectrum Disorders

The purpose of this study is to better understand the long-term progress of people with obsessive-compulsive disorder (OCD) and related conditions such as anorexia nervosa, Tourette syndrome, and trichotillomania.

This study involves the screening and follow-up of individuals with OCD and OCD-related disorders. Participants will be screened with a medical and psychiatric evaluation, questionnaires, and neurological testing. Participants will then have study visits every 4 to 12 weeks to undergo symptom and daily functioning evaluations, personality tests, blood and urine tests, memory tests, brain scans, and other clinical exams. Participants will be assessed with interviews and paper-and-pencil or computer-assisted tests. Participants may have the opportunity to participate in drug studies and to join a monthly OCD support group. At the end of the study, participants will be referred to community or private treatment centers.

Study Overview

• Status: Completed
• Conditions: Anorexia Nervosa; Obsessive Compulsive Disorder; Trichotillomania; Tourette Syndrome

Detailed Description

The purpose of this protocol is to allow for careful screening and follow-up of patients with obsessive-compulsive disorder (OCD) and OCD-related disorders for a variety of protocols, recording demographic and rating information over the long-term course of the OCD illness and associated anxiety and depression symptoms. Patients in this study will be asked to participate in the naturalistic baseline assessment phase to better understand the pathophysiology and long-term course of illness. As a part of this protocol, subjects will be systematically administered assessment measures including diagnostic and psychological screening tests, a psychiatric assessment, SCID I and SCID II interviews, as well as other rating scales. They will also be informed of their opportunity to participate in research procedures such as blood draws and MRI of the brain. Upon conclusion of their participation, they will be referred out to community/private treatment when appropriate. All will be offered participation in an ongoing support group. This protocol will serve as an entry point for individuals with OCD and OCD-related disorders to proceed into other investigation procedures.

• Study Type: Observational
• Enrollment: 400

Contacts and Locations

Study Locations

• United States
  • Maryland
    • Bethesda, Maryland, United States, 20892
      • National Institutes of Health Clinical Center, 9000 Rockville Pike

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

• INCLUSION CRITERIA:

Individuals must fulfill DSM IV criteria for OCD or OCD-related disorders as determined by a complete psychiatric diagnostic interview (SCID-I, using DSM IV-TR).

Individuals must be capable of decision making, and able to comprehend the purpose of the study and to provide informed consent.

Individuals can be included if they have certain medical conditions that have been described to have a higher incidence of OCD/depression and anxiety disorders: e.g., individuals with underlying neurological or neuropsychiatric conditions (e.g., tic disorders or dystonias, including torticollis and blepharospasm), connective tissue disorders, but must show no other serious or acute medical illnesses as determined by a physical exam and standard laboratory examinations.

Individuals must be at least 18 years old.

EXCLUSION CRITERIA:

Alcohol or substance use or dependence of sufficient magnitude to require independent, concurrent treatment intervention (e.g., antabuse or opiate treatment, but not including self-help groups).

Current history of aggressive behavior or current suicidal ideation with plan and intent.

Current active psychosis.

Study Plan

How is the study designed?

Collaborators and Investigators

• Sponsor: National Institute of Mental Health (NIMH)

Publications and helpful links

General Publications

• Wiggs CL, Martin A, Altemus M, Murphy DL. Hypervigilance in patients with obsessive-compulsive disorder. Anxiety. 1996;2(3):123-9. doi: 10.1002/(SICI)1522-7154(1996)2:33.0.CO;2-Q.

Study record dates

Study Major Dates

• Study Start: January 28, 2000
• Study Completion: April 21, 2008

Study Registration Dates

• First Submitted: February 3, 2000
• First Submitted That Met QC Criteria: February 3, 2000
• First Posted (Estimate): February 4, 2000

Study Record Updates

• Last Update Posted (Actual): July 2, 2017
• Last Update Submitted That Met QC Criteria: June 30, 2017
• Last Verified: April 21, 2008

More Information

Terms related to this study

• Keywords: Treatment; OCD; Evaluation; Screening; Transition; Longitudinal; Comorbidity; Obsessive Compulsive Disorder; Follow-Up; OC Spectrum Disorders
• Additional Relevant MeSH Terms: Mental Disorders; Pathologic Processes; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Signs and Symptoms, Digestive; Feeding and Eating Disorders; Genetic Diseases, Inborn; Basal Ganglia Diseases; Movement Disorders; Neurodegenerative Diseases; Personality Disorders; Anxiety Disorders; Heredodegenerative Disorders, Nervous System; Neurodevelopmental Disorders; Disruptive, Impulse Control, and Conduct Disorders; Tic Disorders; Anorexia; Anorexia Nervosa; Disease; Compulsive Personality Disorder; Obsessive-Compulsive Disorder; Trichotillomania; Tourette Syndrome
• Other Study ID Numbers: 000067; 00-M-0067